Efficacy generated by afatinib in a lung adenocarcinoma patient harboring HER2 S310Y mutation

Afatinib exhibits therapeutic efficacy for lung adenocarcinoma patients harboring HER2 exon 20 insertions. HER2 S310Y single site substitution was discovered in recent years and afatinib efficacy for adenocarcinoma patients harboring S310Y mutation has not been reported. We presented a case of a 41-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Main Authors: Wang, Jian, Wen, Yuxin, Ding, Guanggui, Ding, Peikun, Zhang, Lu, Liu, Jing, Zhang, Tengfei, Yang, Lin
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Bedside to Bench Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927689/
https://ncbi.nlm.nih.gov/pubmed/29561699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1449611
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares